Dark
Light
System
Institutional Investment Manager
Broadfin Capital, LLC
Broadfin Capital, LLC (CIK: 0001511901) incorporated in Delaware, located at 300 Park Avenue, 25th Floor, New York, NY. Institutional holdings reported to the SEC.

Institutional Holdings (2015Q2)
Portfolio Summary: 94 holdings with a total value of $1,860,870,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 ISHARES TR 1,750,000 218,505,000 11.74% Put
2 HORIZON PHARMA PLC 4,815,807 167,301,000 8.99%
3 FLAMEL TECHNOLOGIES SA SPONSORED ADR 4,975,184 105,424,000 5.67%
4 HERON THERAPEUTICS INC 2,396,681 74,681,000 4.01%
5 SPDR SER TR 285,000 71,888,000 3.86% Put
6 RETROPHIN INC COM 2,162,928 71,701,000 3.85%
7 PROGENICS PHARMACEUTICALS IN 8,951,169 66,776,000 3.59%
8 EMERGENT BIOSOLUTIONS INC COM 1,760,519 58,009,000 3.12%
9 AEGERION PHARMACEUTICALS INC 2,852,578 54,113,000 2.91%
10 ANGIODYNAMICS INC 2,398,527 39,336,000 2.11%
11 HORIZON PHARMA PLC 1,100,000 38,214,000 2.05% Call
12 IGNYTA INC COM 2,256,546 34,051,000 1.83%
13 PERNIX THERAPEUTICS HLDGS IN 5,075,929 30,049,000 1.61%
14 ADVAXIS INC COM NEW 1,450,094 29,480,000 1.58%
15 BioDelivery Sciences International Inc 3,544,060 28,211,000 1.52%
16 DEPOMED INC 1,167,442 25,053,000 1.35%
17 AMPHASTAR PHARMACEUTICALS IN COM 1,417,956 24,928,000 1.34%
18 ALERE INC 452,423 23,865,000 1.28%
19 NEVRO CORP 419,559 22,551,000 1.21%
20 IDERA PHARMACEUTICALS INC 5,663,845 21,013,000 1.13%
21 RAPTOR PHARMACEUTICAL CORP 1,319,883 20,841,000 1.12%
22 CORIUM INTERNATIONAL INC 1,504,762 20,600,000 1.11%
23 RIGEL PHARMACEUTICAL INC 5,876,752 18,864,000 1.01%
24 LA JOLLA PHARMACEUTICAL CO 759,470 18,615,000 1.00%
25 QLT INC 4,445,527 18,360,000 0.99%
26 SOCIETAL CDMO INC 1,413,533 18,263,000 0.98%
27 SPECTRUM PHARMACEUTICALS INC COM 2,650,000 18,126,000 0.97%
28 ZOGENIX INC 10,737,645 18,039,000 0.97%
29 DYNAVAX TECHNOLOGIES CORP 766,010 17,944,000 0.96%
30 CATALYST PHARMACEUTICALS INC 4,183,177 17,277,000 0.93%
31 ARATANA THERAPEUTICS INC COM 1,131,865 17,114,000 0.92%
32 Lion Biotechnologies 1,812,419 16,620,000 0.89%
33 DERMA SCIENCES INC COM PAR .01 2,317,489 16,593,000 0.89%
34 ANTARES PHARMA INC 7,575,000 15,756,000 0.85%
35 KEMPHARM INC 827,810 15,207,000 0.82%
36 IGI LABS INC 2,287,728 14,413,000 0.77%
37 CYNAPSUS THERAPEUTICS INC 878,117 13,876,000 0.75%
38 PERNIX THERAPEUTICS HLDGS IN 15,500,000 13,837,000 0.74%
39 GENOCEA BIOSCIENCES INC 996,760 13,686,000 0.74%
40 PARATEK PHARMACEUTICALS INC 530,283 13,665,000 0.73%
41 ATRICURE INC 483,354 11,910,000 0.64%
42 ANTHERA PHARMACEUTICALS I 1,370,457 11,813,000 0.63%
43 MIRATI THERAPEUTICS INC COM 359,661 11,319,000 0.61%
44 SYNERON MEDICAL LTD ORD SHS 1,005,221 10,675,000 0.57%
45 ALCOBRA LTD 1,579,806 10,332,000 0.56%
46 ADMA BIOLOGICS, INC. 964,193 8,928,000 0.48%
47 ARDELYX INC COM 649,290 8,877,000 0.48%
48 TREVENA INC 1,409,153 8,821,000 0.47%
49 AMARIN CORP PLC 3,525,216 8,672,000 0.47%
50 Carbylan Therapeutics Inc. 1,178,941 8,429,000 0.45%
Page 1 of 2

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-15-006089, filed 2015.08.14).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.